Mettler-Toledo International Inc at JPMorgan Healthcare Conference Transcript
All right. Great. Hi, everyone. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to be joined by the management team of Mettler-Toledo. We have CEO, Patrick Kaltenbach and CFO, Shawn Vadala.
Following the company presentation, we'll have a Q&A session. But for now, I'll hand it over to Patrick.
Thank you, Casey, and good morning. It's great to be with you today. I'd like to start off today with an overview of the business, share some thoughts with you on our growth strategies and why we are well positioned to continue to deliver excellent shareholder returns.
So before we get started, of course, please note our disclosure regarding forward-looking statements on -- in the slides. So for those of you that are familiar, I'm sure you would agree, we have a great track record of delivering strong financial results. This track record is built on several important factors. First, we have a strong
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |